Furthermore, our previous work and others’ also showed SPARC siRNA effectively reduced fibrosis in SSc dermal fibroblasts, TGF-β1-stimulated fibroblasts, skin and lung tissues from bleomycin-induced mice [18,20,21]. The gene discussed is TGFB1; the disease is systemic sclerosis.